Literature DB >> 11423892

Growth hormone deficiency in autoimmune polyglandular disease type 1.

A S Al-Herbish1, J D Bailey, S W Kooh.   

Abstract

This is a case report of 2 patients who were diagnosed to have autoimmune polyglandular disease type 1. Both developed mucocutaneous candidiasis, hypoparathyroidism, vitiligo, and adrenocortical insufficiency. Both were noticed to have subnormal linear growth velocity and delayed bone age. Both showed subnormal stimulated serum growth hormone values indicating growth hormone deficiency. The first case showed favorable response to growth hormone therapy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11423892

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  2 in total

1.  Pituitary autoantibodies in autoimmune polyendocrine syndrome type 1.

Authors:  Sophie Bensing; Sergueï O Fetissov; Jan Mulder; Jaakko Perheentupa; Jan Gustafsson; Eystein S Husebye; Mikael Oscarson; Olov Ekwall; Patricia A Crock; Tomas Hökfelt; Anna-Lena Hulting; Olle Kämpe
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-10       Impact factor: 11.205

2.  Autoantibodies to IL-17A may be correlated with the severity of mucocutaneous candidiasis in APECED patients.

Authors:  Adrien Katalin Sarkadi; Szilvia Taskó; Gabriella Csorba; Beáta Tóth; Melinda Erdős; László Maródi
Journal:  J Clin Immunol       Date:  2014-02-04       Impact factor: 8.542

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.